New peanut allergy treatment MOON101 enters early safety testing
Disease control
Not yet recruiting
This early-phase study tests whether MOON101 is safe for people with peanut allergy. About 40 adults, teens, and children will receive both the active treatment and a placebo to check for side effects. The goal is to find the highest safe dose and track any reactions.
Phase: PHASE1 • Sponsor: Moonlight Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 09:48 UTC